We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 11,363

CMS Proposes to Reduce Payments for New Drugs under Medicare Part B
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 20 2018

In an attempt to lower drug prices, CMS released a proposed rule last week to reduce payments for new drugs under the Part B program. CMS has proposed


FDA’s New Biosimilar Action Plan Represents the Next Step for Improving Drug Competition
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 19 2018

On July 18, 2018, after months of alluding to the various aspects of an upcoming “Biosimilar Action Plan” as another prong within FDA’s broader Drug


Special Master Recommends Return of $10.6 Million in Attorneys’ Fees to Class Members
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 19 2018

Former U.S. District Judge Gerald Rosen, the Special Master appointed to investigate alleged improper billing by class plaintiffs’ firms in Arkansas


Court of Appeals Weighs in on 340B
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 18 2018

Timing is everything. In yesterday’s post on 340B, I stated in closing: There is still one more shoe to drop. On May 4, 2018, the U.S. Court of


Recent ITC decision clarifies and eases domestic industry burden for patent holders
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 17 2018

A recent decision by the International Trade Commission (“ITC” or the “Commission”) improves intellectual property holders’ ability to prove that they


July 2018: Where Are We Now With 340B?
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 17 2018

It seems like every week, there are multiple new developments in the 340B program. While it has just been a few weeks since my last 340B blog post


Retrogression of Employment Based First Preference Priority Date on August 1, 2018
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 16 2018

According to the State Department August Visa Bulletin, the Employment Based First Preference Category (EB-1) Final Action Dates for “Priority


The Potential Pitfalls of Contesting Arbitrability in the Arbitration
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 16 2018

When an agreement to arbitrate contains a clear and unmistakable “delegation” provision, gateway questions of arbitrability are for the arbitrator to


ML Strategies Health Care Preview - July 16, 2018
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 16 2018

This week, Congress remains in session and the Administration remains hard at work on the regulatory side, publishing the Medicare Physician Fee


Tenth Circuit Revives FCA Claim Based on Alleged Lack of Medical Necessity
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • July 15 2018

The Tenth Circuit Court of Appeals has issued a significant decision, finding that a physician’s medical judgment about the medical necessity of heart